Atlas Trials

A Study of LY3372993 in Healthy Participants and Participants With Alzheimer's Disease (AD)

Clinical trial NCT03720548 · COMPLETED

Trial details

NCT number
NCT03720548
Sponsor
Eli Lilly and Company
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Alzheimer Disease
Start date
2018-11-05
Primary completion
2019-05-14
Enrollment
36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.